Han Kyong Kim

USPTO Granted Patents = 8 (Patent Applications = 2)

CIPO Patents = 1

EPO Patents = 6 (Patent Applications = 5)

Average Co-Inventor Count = 9.2

ph-index = 2

Forward Citations = 20(Granted Patents)

Location History:

Kyungki-do, KR (2010)
Yongin-si, KR (2008 - 2014)

Company Filing History:

4 out of 146

Hanmi Pharm. Co., Ltd.

patents

2 out of 12

Hanmi Holdings Co., Ltd.

Hanmi Science Co., Ltd.

patents

Years Active: 2008-2014

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8846699 - Quinazoline derivatives as a multiplex inhibitor and method for the preparation thereof (2014-09-30),

2. 8637700 - Method for preparing (3S,4S)-4-((R)-2-(benzyloxy)tridecyl)-3-hexyl-2-oxetanone and novel intermediate used therefor (2014-01-28),

3. 8263769 - Process for preparing voriconazole (2012-09-11),

4. 8188102 - Amide derivative for inhibiting the growth of cancer cells (2012-05-29),

5. 7888511 - Method of preparing esomeprazole and salts thereof (2011-02-15),

6. 7858761 - 1-α-halo-2,2-difluoro-2-deoxy-D-ribofuranose derivatives and process for the preparation thereof (2010-12-28),

7. 7799907 - Method for the preparation of 2'-deoxy-2′,2′-difluorocytidine (2010-09-21),

8. 7470707 - Crystalline monohydrate clopidogrel naphthalenedisulfonate and process of preparation (2008-12-30),

Title: Han Kyong Kim: A Pioneer in Technological Advancement

Introduction: Inventor Han Kyong Kim from Yongin-si, South Korea, has solidified his position as a leading figure in the realm of innovators through his unwavering passion for innovation and commitment to excellence. His relentless pursuit of technological advancement continues to influence and shape the future of the industry.

Latest Patents: Han Kyong Kim holds a total of 8 patents, with his latest inventions showcasing his ingenuity. One of his recent patents includes the development of quinazoline derivatives as a multiplex inhibitor, effectively inhibiting diseases caused by the overactivity of a tyrosine kinase. Another notable patent is the method for preparing (3S,4S)-4-((R)-2-(benzyloxy)tridecyl)-3-hexyl-2-oxetanone, demonstrating his expertise in chemical synthesis.

Career Highlights: Han Kyong Kim has made significant contributions to the field through his work with prominent companies such as Hanmi Pharmaceutical Co., Ltd., and Hanmi Holdings Co., Ltd. His innovative solutions have garnered recognition and praise within the industry, solidifying his reputation as a pioneer in technological advancement.

Collaborations: Throughout his career, Han Kyong Kim has had the opportunity to collaborate with esteemed individuals in the field, including Gwan Sun Lee and Young-Kil Chang. These collaborations have led to the development of groundbreaking technologies and further cemented his status as a leader in the industry.

Conclusion: Han Kyong Kim's dedication to innovation, coupled with his remarkable achievements in the field of technological advancement, has positioned him as a prominent inventor whose work continues to inspire and shape the future of the industry. His relentless pursuit of excellence and passion for innovation serve as a testament to his invaluable contributions to the world of inventors.

This text is generated by artificial intelligence and may not be accurate.